Health Canada Provides Positive Feedback on Tetra Bio-Pharma’s (OTC: TBPMF) Application for ARDS-003 to be Studied in COVID-19 Patients at Risk of Developing Acute Respiratory Distress Syndrome
Health Canada acknowledges that the preclinical safety data are robust and sufficient to file a Clinical Trial Application aimed at treating hospitalized COVID-19 patients at risk of developing ARDS ARDS is the leading cause of […]
